Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy.
暂无分享,去创建一个
H. Blomgren | P. Johnston | B. Glimelius | A. Jakobsen | M. Hallström | P. Ragnhammar | D. Edler | I. Magnusson
[1] H. Blomgren,et al. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] G. Peters,et al. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] L. Påhlman,et al. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] J. Ferlay,et al. Estimates of the worldwide mortality from 25 cancers in 1990 , 1999, International journal of cancer.
[5] S. Barni,et al. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] F. Maley,et al. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] P. Johnston,et al. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] S. Groshen,et al. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] S. Groshen,et al. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] H. Blomgren,et al. Immunohistochemical determination of thymidylate synthase in colorectal cancer--methodological studies. , 1997, European journal of cancer.
[11] S. Groshen,et al. Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] S. Groshen,et al. Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial. , 1995, European journal of cancer.
[13] P. Johnston,et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. , 1995, Cancer research.
[14] H E Rockette,et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] B. Glimelius. Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] P. Johnston,et al. Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. , 1991, Cancer research.
[17] T R Fleming,et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.
[18] J. Laurie,et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] T. Fleming,et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] H. Rockette,et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. , 1988, Journal of the National Cancer Institute.
[21] R. Heald,et al. RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCER , 1986, The Lancet.
[22] R. Heald,et al. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? , 1982, The British journal of surgery.
[23] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[24] P. Danenberg. Thymidylate synthetase - a target enzyme in cancer chemotherapy. , 1977, Biochimica et biophysica acta.
[25] E. Gehan. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.
[26] A. Livingstone,et al. Increased thymidylate synthase gene expression in liver metastases from colorectal carcinoma: implications for chemotherapeutic options and survival. , 1999, The cancer journal from Scientific American.
[27] M. Fukushima,et al. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance , 1998, Cancer.
[28] D. Cox. Regression Models and Life-Tables , 1972 .